| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, Helminth | 34 | 2024 | 187 | 4.460 |
Why?
|
| Helminth Proteins | 27 | 2024 | 103 | 3.280 |
Why?
|
| Trichinella spiralis | 20 | 2024 | 22 | 2.890 |
Why?
|
| Ancylostoma | 21 | 2018 | 98 | 2.400 |
Why?
|
| Ascariasis | 7 | 2021 | 73 | 2.110 |
Why?
|
| Protozoan Vaccines | 11 | 2021 | 96 | 1.790 |
Why?
|
| Necator americanus | 12 | 2018 | 90 | 1.480 |
Why?
|
| Vaccines | 13 | 2022 | 382 | 1.460 |
Why?
|
| Recombinant Proteins | 33 | 2025 | 1347 | 1.370 |
Why?
|
| Chagas Disease | 10 | 2025 | 308 | 1.330 |
Why?
|
| Trichinellosis | 11 | 2024 | 14 | 1.300 |
Why?
|
| Antibodies, Helminth | 20 | 2021 | 125 | 1.230 |
Why?
|
| Ancylostomiasis | 14 | 2018 | 62 | 1.230 |
Why?
|
| Trypanosoma cruzi | 9 | 2025 | 250 | 1.190 |
Why?
|
| Onchocerciasis | 4 | 2022 | 22 | 1.140 |
Why?
|
| Ascaris suum | 5 | 2021 | 32 | 1.110 |
Why?
|
| Mice, Inbred BALB C | 29 | 2023 | 1045 | 1.040 |
Why?
|
| Vaccines, Synthetic | 15 | 2022 | 322 | 0.990 |
Why?
|
| Animals | 103 | 2025 | 34782 | 0.970 |
Why?
|
| Adjuvants, Immunologic | 18 | 2022 | 391 | 0.920 |
Why?
|
| Cystatins | 5 | 2024 | 8 | 0.890 |
Why?
|
| Spike Glycoprotein, Coronavirus | 8 | 2023 | 205 | 0.820 |
Why?
|
| Filariasis | 3 | 2018 | 28 | 0.810 |
Why?
|
| Brugia malayi | 3 | 2018 | 40 | 0.810 |
Why?
|
| Vaccination | 18 | 2022 | 1018 | 0.790 |
Why?
|
| Immunoglobulin G | 15 | 2025 | 806 | 0.790 |
Why?
|
| Retinol-Binding Proteins | 3 | 2018 | 21 | 0.760 |
Why?
|
| Sepsis | 6 | 2023 | 515 | 0.750 |
Why?
|
| Necatoriasis | 7 | 2018 | 38 | 0.740 |
Why?
|
| Trichuriasis | 3 | 2022 | 31 | 0.730 |
Why?
|
| Hookworm Infections | 6 | 2018 | 123 | 0.730 |
Why?
|
| Glutathione Transferase | 4 | 2013 | 142 | 0.720 |
Why?
|
| Intestinal Volvulus | 1 | 2022 | 40 | 0.720 |
Why?
|
| Immunodominant Epitopes | 3 | 2015 | 52 | 0.720 |
Why?
|
| Schistosoma japonicum | 4 | 2024 | 10 | 0.700 |
Why?
|
| Tropomyosin | 5 | 2020 | 26 | 0.680 |
Why?
|
| Complement C1q | 4 | 2024 | 18 | 0.660 |
Why?
|
| Amino Acid Sequence | 18 | 2021 | 2669 | 0.630 |
Why?
|
| Neglected Diseases | 2 | 2021 | 152 | 0.630 |
Why?
|
| Immunoglobulin E | 6 | 2021 | 180 | 0.610 |
Why?
|
| Immunization | 6 | 2022 | 312 | 0.600 |
Why?
|
| Toxocariasis | 2 | 2015 | 29 | 0.590 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 34 | 0.580 |
Why?
|
| Antibodies, Protozoan | 10 | 2025 | 94 | 0.580 |
Why?
|
| Mice | 43 | 2024 | 18460 | 0.570 |
Why?
|
| Parasitic Diseases | 1 | 2019 | 60 | 0.560 |
Why?
|
| Cloning, Molecular | 13 | 2021 | 811 | 0.550 |
Why?
|
| Antigens, Protozoan | 5 | 2025 | 78 | 0.540 |
Why?
|
| Gene Expression | 12 | 2021 | 1558 | 0.540 |
Why?
|
| Communicable Disease Control | 1 | 2019 | 141 | 0.530 |
Why?
|
| Saccharomycetales | 6 | 2021 | 38 | 0.520 |
Why?
|
| Larva | 16 | 2019 | 260 | 0.480 |
Why?
|
| Toxocara canis | 1 | 2015 | 7 | 0.480 |
Why?
|
| Dogs | 14 | 2025 | 652 | 0.480 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 2 | 2008 | 21 | 0.480 |
Why?
|
| Molecular Sequence Data | 18 | 2015 | 3770 | 0.460 |
Why?
|
| Cytokines | 16 | 2024 | 1359 | 0.460 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2023 | 761 | 0.450 |
Why?
|
| Antigenic Variation | 1 | 2014 | 42 | 0.450 |
Why?
|
| Hypersensitivity | 4 | 2019 | 196 | 0.440 |
Why?
|
| Leishmaniasis | 2 | 2025 | 40 | 0.430 |
Why?
|
| Leishmania | 3 | 2025 | 35 | 0.420 |
Why?
|
| Disease Models, Animal | 18 | 2024 | 4680 | 0.420 |
Why?
|
| Salivary Proteins and Peptides | 3 | 2020 | 19 | 0.420 |
Why?
|
| Pichia | 10 | 2017 | 56 | 0.420 |
Why?
|
| Immune Evasion | 4 | 2024 | 38 | 0.410 |
Why?
|
| Onchocerca volvulus | 3 | 2019 | 16 | 0.390 |
Why?
|
| Histamine Release | 1 | 2012 | 9 | 0.390 |
Why?
|
| Calreticulin | 2 | 2024 | 23 | 0.390 |
Why?
|
| Basophils | 1 | 2012 | 13 | 0.390 |
Why?
|
| Dendritic Cells | 5 | 2019 | 447 | 0.380 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2012 | 30 | 0.380 |
Why?
|
| Acute Lung Injury | 2 | 2024 | 68 | 0.370 |
Why?
|
| Metalloendopeptidases | 5 | 2007 | 100 | 0.360 |
Why?
|
| Host-Parasite Interactions | 5 | 2019 | 81 | 0.360 |
Why?
|
| Helminths | 2 | 2022 | 48 | 0.360 |
Why?
|
| Vaccines, DNA | 3 | 2016 | 48 | 0.350 |
Why?
|
| Parasite Load | 7 | 2021 | 31 | 0.350 |
Why?
|
| Alum Compounds | 6 | 2022 | 42 | 0.350 |
Why?
|
| Antibodies, Viral | 6 | 2024 | 1203 | 0.340 |
Why?
|
| Cricetinae | 7 | 2018 | 381 | 0.340 |
Why?
|
| Anthelmintics | 3 | 2018 | 55 | 0.340 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2021 | 488 | 0.320 |
Why?
|
| Heme | 1 | 2010 | 52 | 0.310 |
Why?
|
| Chagas Cardiomyopathy | 3 | 2019 | 53 | 0.310 |
Why?
|
| DNA, Complementary | 6 | 2015 | 454 | 0.310 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2023 | 416 | 0.300 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2019 | 227 | 0.300 |
Why?
|
| Trichuris | 3 | 2022 | 26 | 0.300 |
Why?
|
| Soil | 3 | 2021 | 72 | 0.300 |
Why?
|
| Leishmaniasis Vaccines | 2 | 2020 | 20 | 0.290 |
Why?
|
| Dog Diseases | 3 | 2025 | 59 | 0.290 |
Why?
|
| Th2 Cells | 6 | 2021 | 188 | 0.290 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2020 | 131 | 0.290 |
Why?
|
| Gerbillinae | 3 | 2018 | 55 | 0.290 |
Why?
|
| Female | 45 | 2025 | 70586 | 0.280 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2025 | 822 | 0.280 |
Why?
|
| Ancylostomatoidea | 3 | 2018 | 60 | 0.270 |
Why?
|
| Humans | 45 | 2025 | 131929 | 0.270 |
Why?
|
| Inflammation | 6 | 2023 | 1519 | 0.270 |
Why?
|
| China | 6 | 2019 | 290 | 0.270 |
Why?
|
| Variant Surface Glycoproteins, Trypanosoma | 2 | 2018 | 6 | 0.260 |
Why?
|
| DNA, Helminth | 2 | 2010 | 23 | 0.260 |
Why?
|
| Immunogenicity, Vaccine | 2 | 2019 | 114 | 0.260 |
Why?
|
| N-Glycosyl Hydrolases | 2 | 2016 | 13 | 0.250 |
Why?
|
| Psychodidae | 2 | 2017 | 14 | 0.250 |
Why?
|
| Leishmania donovani | 2 | 2016 | 24 | 0.250 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2018 | 74 | 0.250 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2017 | 38 | 0.240 |
Why?
|
| Colitis | 2 | 2020 | 165 | 0.240 |
Why?
|
| Hemeproteins | 1 | 2005 | 7 | 0.240 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2023 | 55 | 0.240 |
Why?
|
| Hemolysin Proteins | 2 | 2018 | 29 | 0.240 |
Why?
|
| Endotoxins | 2 | 2018 | 48 | 0.240 |
Why?
|
| Protein Binding | 5 | 2024 | 1730 | 0.240 |
Why?
|
| Lung | 7 | 2024 | 1555 | 0.240 |
Why?
|
| Protozoan Proteins | 2 | 2016 | 133 | 0.230 |
Why?
|
| Malaria, Falciparum | 2 | 2022 | 70 | 0.230 |
Why?
|
| Paraquat | 1 | 2024 | 14 | 0.220 |
Why?
|
| Plasmodium falciparum | 2 | 2022 | 96 | 0.220 |
Why?
|
| Carrier Proteins | 3 | 2015 | 1046 | 0.220 |
Why?
|
| Vaccines, Subunit | 5 | 2021 | 70 | 0.210 |
Why?
|
| Dengue | 1 | 2025 | 122 | 0.210 |
Why?
|
| Echinococcus granulosus | 1 | 2023 | 2 | 0.210 |
Why?
|
| Immunotherapy | 3 | 2018 | 744 | 0.210 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2022 | 441 | 0.210 |
Why?
|
| Epitopes | 2 | 2016 | 436 | 0.210 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2020 | 353 | 0.210 |
Why?
|
| Protein Domains | 5 | 2021 | 260 | 0.200 |
Why?
|
| Sequence Alignment | 7 | 2017 | 615 | 0.200 |
Why?
|
| Spleen | 4 | 2016 | 270 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2008 | 1284 | 0.200 |
Why?
|
| Parasites | 1 | 2023 | 36 | 0.200 |
Why?
|
| Dextran Sulfate | 2 | 2020 | 47 | 0.200 |
Why?
|
| Macrophages | 6 | 2024 | 688 | 0.190 |
Why?
|
| Electron Transport Complex IV | 2 | 2001 | 41 | 0.190 |
Why?
|
| Onchocerca | 1 | 2022 | 6 | 0.190 |
Why?
|
| Ivermectin | 1 | 2022 | 8 | 0.190 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2014 | 1017 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 7 | 2023 | 4751 | 0.180 |
Why?
|
| Complement Pathway, Classical | 2 | 2024 | 3 | 0.180 |
Why?
|
| Blindness | 1 | 2022 | 76 | 0.180 |
Why?
|
| Immunoglobulin M | 2 | 2024 | 216 | 0.180 |
Why?
|
| Neutrophils | 2 | 2020 | 361 | 0.170 |
Why?
|
| Immunomodulation | 2 | 2018 | 78 | 0.170 |
Why?
|
| Serologic Tests | 2 | 2025 | 130 | 0.170 |
Why?
|
| Extracellular Traps | 1 | 2020 | 7 | 0.170 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 246 | 0.170 |
Why?
|
| DNA, Kinetoplast | 1 | 2020 | 3 | 0.170 |
Why?
|
| Viral Vaccines | 2 | 2014 | 343 | 0.170 |
Why?
|
| Immunity | 2 | 2018 | 183 | 0.170 |
Why?
|
| Skin | 3 | 2012 | 527 | 0.170 |
Why?
|
| Cattle | 1 | 2022 | 569 | 0.170 |
Why?
|
| Bodily Secretions | 1 | 2020 | 7 | 0.170 |
Why?
|
| Th1 Cells | 5 | 2022 | 156 | 0.170 |
Why?
|
| Macrophages, Peritoneal | 1 | 2020 | 39 | 0.170 |
Why?
|
| Phlebotomus | 1 | 2020 | 16 | 0.170 |
Why?
|
| Leishmaniasis, Cutaneous | 2 | 2020 | 49 | 0.170 |
Why?
|
| Asthma | 2 | 2019 | 772 | 0.170 |
Why?
|
| Base Sequence | 6 | 2004 | 2899 | 0.160 |
Why?
|
| Insect Proteins | 1 | 2020 | 111 | 0.160 |
Why?
|
| Bacterial Proteins | 2 | 2018 | 930 | 0.160 |
Why?
|
| Phylogeny | 3 | 2020 | 763 | 0.160 |
Why?
|
| Germinal Center | 1 | 2020 | 37 | 0.160 |
Why?
|
| Cell Polarity | 1 | 2020 | 124 | 0.160 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2020 | 34 | 0.160 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2015 | 651 | 0.160 |
Why?
|
| Coinfection | 1 | 2021 | 189 | 0.160 |
Why?
|
| Cysteine | 2 | 2017 | 142 | 0.160 |
Why?
|
| Tissue Extracts | 1 | 2019 | 12 | 0.160 |
Why?
|
| B-Lymphocytes | 2 | 2020 | 540 | 0.160 |
Why?
|
| Prevalence | 4 | 2025 | 2658 | 0.160 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2020 | 130 | 0.150 |
Why?
|
| Helminthiasis | 2 | 2021 | 80 | 0.150 |
Why?
|
| Circular Dichroism | 1 | 2018 | 80 | 0.150 |
Why?
|
| T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2018 | 2 | 0.150 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 207 | 0.150 |
Why?
|
| Bacillus thuringiensis | 1 | 2018 | 1 | 0.140 |
Why?
|
| Blotting, Western | 2 | 2015 | 1077 | 0.140 |
Why?
|
| Protective Agents | 1 | 2018 | 36 | 0.140 |
Why?
|
| Vitamin A | 1 | 2018 | 56 | 0.140 |
Why?
|
| Arthritis, Experimental | 1 | 2018 | 22 | 0.140 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2018 | 51 | 0.140 |
Why?
|
| Male | 23 | 2025 | 64872 | 0.140 |
Why?
|
| Milk Proteins | 1 | 2018 | 86 | 0.140 |
Why?
|
| Protein Structure, Secondary | 1 | 2018 | 246 | 0.140 |
Why?
|
| Antibodies, Neutralizing | 4 | 2023 | 501 | 0.140 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2018 | 62 | 0.140 |
Why?
|
| Interferon-gamma | 5 | 2019 | 534 | 0.140 |
Why?
|
| Mice, Inbred ICR | 4 | 2020 | 151 | 0.140 |
Why?
|
| Parasitemia | 4 | 2019 | 26 | 0.140 |
Why?
|
| Superantigens | 1 | 2017 | 20 | 0.130 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 679 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2018 | 140 | 0.130 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2023 | 100 | 0.130 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2016 | 46 | 0.130 |
Why?
|
| Salmonella typhimurium | 1 | 2016 | 43 | 0.130 |
Why?
|
| Immunoglobulin A | 3 | 2024 | 219 | 0.120 |
Why?
|
| Metalloproteases | 2 | 2007 | 15 | 0.120 |
Why?
|
| 14-3-3 Proteins | 1 | 2016 | 57 | 0.120 |
Why?
|
| Sensitivity and Specificity | 4 | 2025 | 2140 | 0.120 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2017 | 162 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 1046 | 0.120 |
Why?
|
| Escherichia coli | 3 | 2015 | 995 | 0.120 |
Why?
|
| Lectins | 1 | 2015 | 49 | 0.120 |
Why?
|
| Mutant Proteins | 1 | 2016 | 116 | 0.120 |
Why?
|
| Parasite Egg Count | 5 | 2012 | 28 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 509 | 0.120 |
Why?
|
| Aging | 2 | 2018 | 1248 | 0.110 |
Why?
|
| Seroepidemiologic Studies | 2 | 2025 | 144 | 0.110 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2015 | 151 | 0.110 |
Why?
|
| Treatment Outcome | 7 | 2020 | 12994 | 0.110 |
Why?
|
| Endemic Diseases | 2 | 2024 | 59 | 0.110 |
Why?
|
| Middle East Respiratory Syndrome Coronavirus | 1 | 2014 | 22 | 0.110 |
Why?
|
| Genome, Helminth | 1 | 2014 | 12 | 0.110 |
Why?
|
| Immune Sera | 2 | 2004 | 89 | 0.110 |
Why?
|
| Ascaris lumbricoides | 1 | 2014 | 19 | 0.110 |
Why?
|
| Immunity, Cellular | 3 | 2022 | 201 | 0.110 |
Why?
|
| Immunization, Secondary | 1 | 2014 | 113 | 0.100 |
Why?
|
| Schistosomiasis mansoni | 1 | 2013 | 24 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2013 | 31 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2018 | 498 | 0.100 |
Why?
|
| Molecular Weight | 3 | 2020 | 309 | 0.100 |
Why?
|
| Crystallography, X-Ray | 3 | 2024 | 388 | 0.100 |
Why?
|
| Survival Analysis | 4 | 2018 | 1572 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2005 | 2674 | 0.100 |
Why?
|
| Peptides | 2 | 2020 | 846 | 0.100 |
Why?
|
| Complement Activation | 2 | 2024 | 49 | 0.100 |
Why?
|
| Mozambique | 2 | 2022 | 22 | 0.090 |
Why?
|
| Biological Products | 1 | 2014 | 137 | 0.090 |
Why?
|
| Immunoglobulins | 1 | 2012 | 169 | 0.090 |
Why?
|
| Molecular Docking Simulation | 2 | 2024 | 142 | 0.090 |
Why?
|
| Administration, Intranasal | 2 | 2022 | 140 | 0.090 |
Why?
|
| Esophagus | 2 | 2011 | 234 | 0.090 |
Why?
|
| Colon | 1 | 2014 | 370 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2020 | 3860 | 0.080 |
Why?
|
| Mice, Inbred AKR | 2 | 2022 | 14 | 0.080 |
Why?
|
| Mesocricetus | 3 | 2012 | 74 | 0.080 |
Why?
|
| Genetic Vectors | 3 | 2020 | 925 | 0.080 |
Why?
|
| Factor Xa Inhibitors | 1 | 2011 | 66 | 0.080 |
Why?
|
| Aluminum Hydroxide | 1 | 2010 | 39 | 0.080 |
Why?
|
| Lipid Peroxidation | 1 | 2010 | 93 | 0.080 |
Why?
|
| Open Reading Frames | 1 | 2010 | 218 | 0.080 |
Why?
|
| Mucous Membrane | 2 | 2022 | 90 | 0.080 |
Why?
|
| Ovalbumin | 2 | 2019 | 123 | 0.080 |
Why?
|
| Lipopolysaccharides | 2 | 2023 | 306 | 0.080 |
Why?
|
| Protein Conformation | 2 | 2024 | 827 | 0.070 |
Why?
|
| Binding Sites | 3 | 2018 | 1256 | 0.070 |
Why?
|
| Matrix Metalloproteinases, Secreted | 1 | 2008 | 4 | 0.070 |
Why?
|
| Coronavirus Infections | 1 | 2014 | 380 | 0.070 |
Why?
|
| Glutathione | 1 | 2010 | 200 | 0.070 |
Why?
|
| Interleukin-5 | 2 | 2018 | 47 | 0.070 |
Why?
|
| Viral Load | 2 | 2021 | 404 | 0.070 |
Why?
|
| Interleukin-4 | 2 | 2018 | 145 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2012 | 275 | 0.070 |
Why?
|
| Gene Expression Regulation | 4 | 2018 | 2437 | 0.070 |
Why?
|
| Species Specificity | 2 | 2014 | 541 | 0.070 |
Why?
|
| Fatty Acids | 2 | 2015 | 356 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2012 | 351 | 0.060 |
Why?
|
| Monocytes | 2 | 2019 | 340 | 0.060 |
Why?
|
| Immunologic Factors | 2 | 2020 | 183 | 0.060 |
Why?
|
| Adult | 8 | 2025 | 31538 | 0.060 |
Why?
|
| Interleukin-10 | 2 | 2018 | 187 | 0.060 |
Why?
|
| Pandemics | 1 | 2014 | 1183 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2018 | 76 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2018 | 84 | 0.060 |
Why?
|
| Intestines | 4 | 2004 | 604 | 0.060 |
Why?
|
| Connective Tissue | 1 | 2006 | 28 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2011 | 608 | 0.060 |
Why?
|
| Ecuador | 1 | 2025 | 15 | 0.060 |
Why?
|
| Young Adult | 3 | 2025 | 9952 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 2 | 2019 | 381 | 0.060 |
Why?
|
| Myocardium | 2 | 2020 | 906 | 0.060 |
Why?
|
| Adolescent | 6 | 2025 | 20535 | 0.050 |
Why?
|
| Herbicides | 1 | 2024 | 14 | 0.050 |
Why?
|
| Chromatography, Gel | 2 | 2016 | 83 | 0.050 |
Why?
|
| Dengue Virus | 1 | 2025 | 132 | 0.050 |
Why?
|
| Antigens, Surface | 1 | 2004 | 117 | 0.050 |
Why?
|
| Cyst Fluid | 1 | 2023 | 6 | 0.050 |
Why?
|
| Africa | 1 | 2024 | 135 | 0.050 |
Why?
|
| Africa South of the Sahara | 1 | 2024 | 121 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 112 | 0.050 |
Why?
|
| Gene Library | 1 | 2004 | 213 | 0.050 |
Why?
|
| Vaccines, Combined | 1 | 2023 | 39 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2016 | 431 | 0.050 |
Why?
|
| Malaria | 1 | 2024 | 99 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 1693 | 0.050 |
Why?
|
| Europe | 1 | 2024 | 372 | 0.050 |
Why?
|
| DNA, Mitochondrial | 2 | 2001 | 242 | 0.050 |
Why?
|
| Caenorhabditis elegans | 2 | 2015 | 243 | 0.050 |
Why?
|
| Anemia | 1 | 2007 | 350 | 0.050 |
Why?
|
| Schistosoma | 1 | 2022 | 13 | 0.050 |
Why?
|
| Technology | 1 | 2023 | 69 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 3011 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2022 | 128 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2022 | 94 | 0.040 |
Why?
|
| Heart | 2 | 2016 | 689 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2016 | 2507 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2001 | 261 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 305 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2022 | 274 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2025 | 1440 | 0.040 |
Why?
|
| Child | 5 | 2025 | 25761 | 0.040 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 1743 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2021 | 190 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 46 | 0.040 |
Why?
|
| DNA, Protozoan | 1 | 2020 | 32 | 0.040 |
Why?
|
| Aged | 5 | 2025 | 21387 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 65 | 0.040 |
Why?
|
| Fermentation | 1 | 2020 | 69 | 0.040 |
Why?
|
| Genetics, Population | 1 | 2001 | 188 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2020 | 60 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 136 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 168 | 0.040 |
Why?
|
| Feces | 3 | 2012 | 755 | 0.040 |
Why?
|
| Macaca mulatta | 1 | 2021 | 501 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2020 | 265 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2025 | 14732 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2020 | 181 | 0.040 |
Why?
|
| Anti-Allergic Agents | 1 | 2019 | 27 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 75 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2021 | 764 | 0.040 |
Why?
|
| Chemokines | 1 | 2019 | 129 | 0.040 |
Why?
|
| Peptide Mapping | 1 | 2018 | 40 | 0.040 |
Why?
|
| Ascaris | 1 | 2018 | 10 | 0.040 |
Why?
|
| Ligands | 2 | 2015 | 494 | 0.040 |
Why?
|
| Rats | 3 | 2020 | 3608 | 0.040 |
Why?
|
| Middle Aged | 5 | 2025 | 28945 | 0.040 |
Why?
|
| Swine Diseases | 1 | 2018 | 42 | 0.040 |
Why?
|
| Biomarkers | 2 | 2019 | 3405 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 149 | 0.040 |
Why?
|
| Interleukin-13 | 1 | 2018 | 94 | 0.040 |
Why?
|
| Receptors, CXCR3 | 1 | 2018 | 22 | 0.040 |
Why?
|
| Eosinophils | 1 | 2019 | 122 | 0.040 |
Why?
|
| Receptors, CCR2 | 1 | 2018 | 24 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 540 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 1547 | 0.030 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2018 | 40 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2017 | 54 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 2017 | 51 | 0.030 |
Why?
|
| Fibrosis | 1 | 2019 | 421 | 0.030 |
Why?
|
| Cecum | 1 | 2017 | 28 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 601 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2017 | 158 | 0.030 |
Why?
|
| Pyroglyphidae | 1 | 2016 | 7 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2016 | 15 | 0.030 |
Why?
|
| Receptors, CCR10 | 1 | 2016 | 1 | 0.030 |
Why?
|
| Receptors, CCR | 1 | 2016 | 2 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2016 | 8 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2017 | 119 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 83 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2017 | 133 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 293 | 0.030 |
Why?
|
| Serine | 1 | 2017 | 166 | 0.030 |
Why?
|
| Complement C8 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Complement C9 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Vaccines, Attenuated | 1 | 2016 | 176 | 0.030 |
Why?
|
| Cell Line | 1 | 2021 | 2718 | 0.030 |
Why?
|
| Dynamic Light Scattering | 1 | 2016 | 9 | 0.030 |
Why?
|
| Body Weight | 2 | 2014 | 994 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 422 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2016 | 128 | 0.030 |
Why?
|
| Workflow | 1 | 2016 | 135 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 1799 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 333 | 0.030 |
Why?
|
| Genes, Helminth | 1 | 2015 | 22 | 0.030 |
Why?
|
| Hemolysis | 1 | 2015 | 106 | 0.030 |
Why?
|
| Lipid A | 1 | 2015 | 24 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2016 | 347 | 0.030 |
Why?
|
| Crystallization | 1 | 2015 | 89 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 1180 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2016 | 151 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2015 | 120 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2017 | 433 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2015 | 201 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 599 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2015 | 98 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2017 | 595 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 664 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2014 | 69 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 413 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 698 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2017 | 471 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2014 | 51 | 0.030 |
Why?
|
| Muscles | 1 | 2014 | 238 | 0.030 |
Why?
|
| Glycosylation | 1 | 2013 | 126 | 0.030 |
Why?
|
| Schistosoma mansoni | 1 | 2013 | 24 | 0.030 |
Why?
|
| Technology, Pharmaceutical | 1 | 2013 | 20 | 0.030 |
Why?
|
| Reproduction | 1 | 2015 | 226 | 0.030 |
Why?
|
| Biotechnology | 1 | 2013 | 59 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 409 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2013 | 223 | 0.020 |
Why?
|
| Transcriptome | 1 | 2019 | 1122 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2016 | 289 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2014 | 362 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 1117 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1881 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2014 | 358 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2014 | 389 | 0.020 |
Why?
|
| Diarrhea | 1 | 2014 | 330 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2014 | 791 | 0.020 |
Why?
|
| Time Factors | 2 | 2016 | 6440 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 1034 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 3037 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2011 | 130 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 13047 | 0.020 |
Why?
|
| Global Health | 1 | 2014 | 643 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2025 | 17374 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 424 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 196 | 0.010 |
Why?
|
| Sex Ratio | 1 | 2004 | 12 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2005 | 322 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2005 | 795 | 0.010 |
Why?
|
| Brazil | 1 | 2003 | 140 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 6226 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2004 | 296 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2003 | 196 | 0.010 |
Why?
|
| Gastrointestinal Tract | 1 | 2005 | 232 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 636 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 7097 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 1221 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 7543 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1161 | 0.010 |
Why?
|
| Haplotypes | 1 | 2001 | 544 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 742 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 1233 | 0.010 |
Why?
|
| Sex Factors | 1 | 2002 | 1351 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 1422 | 0.010 |
Why?
|
| Radiation Injuries, Experimental | 1 | 1967 | 23 | 0.010 |
Why?
|
| Age Factors | 1 | 2002 | 2912 | 0.010 |
Why?
|
| Diet | 1 | 1967 | 1125 | 0.010 |
Why?
|
| Risk Factors | 1 | 2002 | 10933 | 0.000 |
Why?
|
| Lactobacillus | 1 | 1967 | 42 | 0.000 |
Why?
|
| Edible Grain | 1 | 1967 | 45 | 0.000 |
Why?
|
| Meat | 1 | 1967 | 45 | 0.000 |
Why?
|
| Lactose | 1 | 1967 | 55 | 0.000 |
Why?
|
| Enterobacteriaceae | 1 | 1967 | 41 | 0.000 |
Why?
|